Syntrix
Illumina has asked a federal court to dismiss a six-month-old trademark infringement lawsuit against Illumavista Biosciences following an apparent out-of-court settlement.
While Syntrix Biosystems may have played a role in developing foundational microarray technology, the company does not intend to use a large, recently awarded royalty payment from Illumina to expand its presence in the array market.
This story was originally posted on March 15.
Court Orders Illumina to Pay Syntrix $96M for Patent Infringement
NEW YORK (GenomeWeb News) – A federal court jury has ordered Illumina to pay $96 million in damages to Syntrix Biosystems in a patent infringement case.
A jury is considering whether Illumina has infringed the intellectual property of Syntrix, a company with whom the San Diego vendor discussed a potential business relationship more than a decade ago.
Feb 8, 2011
Nov 30, 2010